Correlation Between Oncolytics Biotech and Data Communications

Can any of the company-specific risk be diversified away by investing in both Oncolytics Biotech and Data Communications at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncolytics Biotech and Data Communications into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oncolytics Biotech and Data Communications Management, you can compare the effects of market volatilities on Oncolytics Biotech and Data Communications and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncolytics Biotech with a short position of Data Communications. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncolytics Biotech and Data Communications.

Diversification Opportunities for Oncolytics Biotech and Data Communications

-0.45

Correlation Coefficient

Oncolytics Biotech  Data Communications

Very good diversification

The 3 months correlation between Oncolytics and Data is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Oncolytics Biotech and Data Communications Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Data Communications and Oncolytics Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncolytics Biotech are associated (or correlated) with Data Communications. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Data Communications has no effect on the direction of Oncolytics Biotech i.e., Oncolytics Biotech and Data Communications go up and down completely randomly.

Pair Corralation between Oncolytics Biotech and Data Communications

Assuming the 90 days trading horizon Oncolytics Biotech is expected to generate 2.75 times more return on investment than Data Communications. However, Oncolytics Biotech is 2.75 times more volatile than Data Communications Management. It trades about 0.21 of its potential returns per unit of risk. Data Communications Management is currently generating about -0.09 per unit of risk. If you would invest  60.00  in Oncolytics Biotech on May 20, 2025 and sell it today you would earn a total of  89.00  from holding Oncolytics Biotech or generate 148.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Oncolytics Biotech  vs.  Data Communications Management

Oncolytics Biotech

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Oncolytics Biotech are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Oncolytics Biotech displayed solid returns over the last few months and may actually be approaching a breakup point.

Data Communications

Risk-Adjusted Performance

Weakest

Over the last 90 days Data Communications Management has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's primary indicators remain very healthy which may send shares a bit higher in September 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Oncolytics Biotech and Data Communications

The main advantage of trading using opposite Oncolytics Biotech and Data Communications positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncolytics Biotech position performs unexpectedly, Data Communications can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Data Communications will offset losses from the drop in Data Communications' long position.

The idea behind Oncolytics Biotech and Data Communications Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.